| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 104.2M -35.0% | 160.3M +0.5% | 159.6M +39.5% | 114.4M -13.2% | 131.8M |
| R&D | 85.0M -40.4% | 142.6M +0.2% | 142.3M +43.8% | 98.9M -13.4% | 114.2M |
| SG&A | 19.1M +8.2% | 17.7M +2.5% | 17.3M +11.8% | 15.4M -11.8% | 17.5M |
| Operating Income | -104155000 +35.0% | -160323000 -0.5% | -159554000 -39.5% | -114362000 +13.2% | -131762000 |
| EBITDA | -104066000 +35.1% | -160231000 -0.5% | -159458000 -39.6% | -114261000 +13.2% | -131657000 |
| Net Income | -97246000 +36.5% | -153224000 -3.6% | -147856000 -33.6% | -110635000 +12.5% | -126502000 |
| EPS (Basic) | $-0.47 +37.3% | $-0.75 -2.7% | $-0.73 -19.7% | $-0.61 +16.4% | $-0.73 |
| EPS (Diluted) | $-0.47 +37.3% | $-0.75 -2.7% | $-0.73 -19.7% | $-0.61 +16.4% | $-0.73 |
| Shares (Diluted) | 206.7M +0.5% | 205.5M +0.9% | 203.7M +12.2% | 181.5M +4.5% | 173.6M |